Art

J-GLOBAL ID：201102293993447169   Reference number：11A0711287

眼科医のための先端医療 第123回 眼内悪性リンパ腫の新たな治療法

Author (1)： OTA KOICHI (松本歯大 歯 眼科)
Material： あたらしい眼科  (Journal of the Eye)
Volume： 28  Issue： 3  Page： 383-385  Publication year： Mar. 30, 2011 
JST Material Number： Y0754A  ISSN： 0910-1810  CODEN： ATGAEX  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： primary intraocular lymphoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0711287&from=J-GLOBAL&jstjournalNo=Y0754A") }}

JST classification (3)： Eye tumors(=neoplasms)  (GP04000B) ,  Clinical oncology in general  (GE03010Y) ,  Tumors(=neoplasms)of nervous system  (GN04000V)

Substance index (1)： Methotrexate

Reference (8)：

• CHAN, CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003, 101, 275-292
• BOEHME, V. CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab : an analysis of patients treated in the RICOVER-60 trial of the German High-grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Blood. 2009, 113, 3896-3902
• SMITH, JR. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002, 109, 1709-1716
• OHGURO, N. Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma. Arch Ophthalmol. 2008, 126, 1002-1003
• OHTA, K. Cytokine and molecular analyses of intraocular lymphoma. Ocul Immunol Inflamm. 2009, 17, 142-147

Terms in the title (4)： 眼科医 ,  先端医療 ,  眼内悪性リンパ腫 ,  治療法